Form 4: Marsh & McLennan Companies Executive Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Nicholas Mark Studer, President and CEO of Oliver Wyman Group (OWG) at Marsh & McLennan Companies, exercised stock options and sold shares to cover exercise costs and tax obligations on March 12, 2025.
Summary
- On March 12, 2025, Nicholas Mark Studer, President and CEO of OWG at Marsh & McLennan Companies, exercised stock options to acquire a total of 70,936 shares of common stock at prices ranging from $57.325 to $200.468.
- Studer then sold 49,390 shares of common stock at a weighted average price of $230.1629 per share to satisfy exercise price and tax withholding obligations.
- Following these transactions, Studer directly owns 28,329 shares of Marsh & McLennan Companies common stock.
- Studer also holds options to purchase 25,777 additional shares of common stock at prices ranging from $151.368 to $200.468.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock option exercises and share sales, which is a neutral event from an investment perspective.
Industry Context
Executive stock option exercises and sales are a common occurrence in publicly traded companies and are generally viewed in the context of executive compensation and alignment with shareholder interests.
Comparison to Industry Standards
- Executive compensation practices, including stock options, are benchmarked against peer companies in the financial services and insurance brokerage industries.
- Companies like Aon, Willis Towers Watson, and Brown & Brown are often used as comparables when evaluating executive compensation packages at Marsh & McLennan.
Stakeholder Impact
- The transaction has a minor impact on shareholders due to the increase in outstanding shares from option exercises and the subsequent sale of shares in the open market.
Key Dates
| Date | Description |
|---|---|
| 02/22/2016 | Date when some of the options were granted, vesting in four equal annual installments. |
| 02/21/2018 | Date when some of the options were granted, vesting in four equal annual installments. |
| 02/19/2019 | Date when some of the options were granted, vesting in four equal annual installments. |
| 02/19/2020 | Date when some of the options were granted, vesting in four equal annual installments. |
| 02/22/2021 | Date when some of the options were granted, vesting in four equal annual installments. |
| 02/23/2022 | Date when some of the options were granted, vesting in four equal annual installments. |
| 02/23/2023 | Date when some of the options were granted, vesting in four equal annual installments. |
| 02/22/2024 | Date when some of the options were granted, vesting in four equal annual installments. |
| 03/12/2025 | Date of the stock option exercise and share sale. |
| 03/14/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.